TW201842316A - Device for monitoring ketogenic diet efficacy - Google Patents

Device for monitoring ketogenic diet efficacy Download PDF

Info

Publication number
TW201842316A
TW201842316A TW107111853A TW107111853A TW201842316A TW 201842316 A TW201842316 A TW 201842316A TW 107111853 A TW107111853 A TW 107111853A TW 107111853 A TW107111853 A TW 107111853A TW 201842316 A TW201842316 A TW 201842316A
Authority
TW
Taiwan
Prior art keywords
ketogenic diet
animal
ketogenic
acetone
diet
Prior art date
Application number
TW107111853A
Other languages
Chinese (zh)
Other versions
TWI816666B (en
Inventor
芦田欣也
Original Assignee
日商明治股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商明治股份有限公司 filed Critical 日商明治股份有限公司
Publication of TW201842316A publication Critical patent/TW201842316A/en
Application granted granted Critical
Publication of TWI816666B publication Critical patent/TWI816666B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/497Physical analysis of biological material of gaseous biological material, e.g. breath
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/200833Carbonyl, ether, aldehyde or ketone containing
    • Y10T436/202499Formaldehyde or acetone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25875Gaseous sample or with change of physical state

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The purpose of the present invention is to obtain a ketogenic diet monitoring device for individually managing ketogenic diet efficacy in animals. This ketogenic diet monitoring device is configured to monitor by measuring, once or multiple times over time, the volume of metabolites in gas expelled from the interior to the exterior of the body of an animal in which ketogenic diet efficacy is being managed. The ketogenic monitoring device 1 comprises: an intake information acquiring unit for acquiring information on the volume of ketogenic diet being taken into the body of the animal; an acetone concentration measuring unit for measuring acetone concentration, which is the volume of acetone in gas expelled from the interior to the exterior of the body of the animal; and an assessing unit for assessing the ketogenic diet metabolic state of the animal on the basis of the ketogenic diet intake volume information acquired by the intake information acquiring unit and the acetone concentration information measured by the acetone concentration measuring unit.

Description

生酮飲食之有效狀態之監測裝置Monitoring device for effective state of ketogenic diet

本發明係一種用以管理生酮飲食之有效狀態之監測裝置。The invention is a monitoring device for managing the effective state of a ketogenic diet.

在此之前,猜想生酮飲食、高脂肪飲食(尤其是糖類限制高脂肪飲食)可成為針對終末期癌症患者之治療方法之一,於是對生酮飲食對日本國人之終末期肺癌患者之有效性進行了研究,結果發現:藉由生酮飲食、例如包括糖類限制高脂肪飲食此類用以治療癌症之組合物或其等之組合,較佳為藉由將脂肪設為120 g以上,及/或將碳水化合物限制於每日30 g以下,及/或將每日攝取之卡路里設為20 kcal/kg體重以上,及/或將中鏈脂肪酸油(MCT油)等進行組合,會以出乎意料之顯著效果治療癌症,改善生活品質(QOL,Quality of life)(專利文獻1)。 又,已知生酮飲食能有效改善腦功能及預防、治療認知功能障礙(專利文獻2)。進而,已知生酮飲食對肥胖症、循環器官疾病、2型糖尿病、癲癇、痤瘡、癌症、多嚢性卵巢症候群、神經障礙、阿茲海默症、帕金森氏症、頭部外傷具有療效(非專利文獻1)。 在此之前,為了提供一種用以抑制胃排出量之上升且延遲胃排出之食品用劑或醫療用劑,曾進行銳意研究,於此過程中發現了如下方法,即:藉由對被投予13C標記之各種胺基酸之動物的13CO2 之呼氣排泄量進行監測,而將呼氣作為檢體,非侵入性地測定胺基酸之代謝量(專利文獻3)。 根據一般認知,動物所攝取之生酮飲食於動物體內會被代謝,其一部分成為丙酮,而作為呼氣或者自皮膚或黏膜排出體外之氣體,自動物體內向體外排泄。 作為氣體中之丙酮之測定方法,已知有多功能呼氣分析器(專利文獻4)、呼氣測定裝置(專利文獻5)等。 又,已知有利用呼氣丙酮量來推定糖尿病指標值之系統(專利文獻6)。 [先前技術文獻] [專利文獻] 專利文獻1:國際公開第2017/038101號公報 專利文獻2:國際公開第2016/013617號公報 專利文獻3:日本專利第5938219號公報 專利文獻4:日本專利第5921562號公報 專利文獻5:日本專利第5139186號公報 專利文獻6:日本專利特開2015-102381號公報 [非專利文獻] 非專利文獻1:European Journal of Clinical Nu trition (2013) 67, 789-796Prior to this, it was suspected that ketogenic diets and high-fat diets (especially high-fat diets with limited sugars) could become one of the treatments for patients with end-stage cancer, so the effectiveness of ketogenic diets for Japanese patients with end-stage lung cancer A study was conducted and it was found that a composition for treating cancer by a ketogenic diet, such as a high-fat diet including sugars, or a combination thereof, preferably by setting the fat to 120 g or more, and / Or limit carbohydrates to less than 30 g per day, and / or set daily calories to be above 20 kcal / kg body weight, and / or combine medium chain fatty acid oil (MCT oil), etc. The expected remarkable effect is to treat cancer and improve quality of life (QOL) (Patent Document 1). In addition, it is known that a ketogenic diet can effectively improve brain function and prevent and treat cognitive dysfunction (Patent Document 2). Furthermore, the ketogenic diet is known to be effective for obesity, circulatory organ diseases, type 2 diabetes, epilepsy, acne, cancer, multi-ovarian syndrome, neurological disorders, Alzheimer's disease, Parkinson's disease, and head trauma ( Non-patent literature 1). Prior to this, in order to provide a food or medical agent for suppressing the increase of gastric discharge and delaying gastric discharge, a vigorous research was conducted, and the following methods were found in the process, namely: by administering 13C 2 animals with various amino acids labeled with 13C are monitored for the amount of 13CO 2 exhaled air, and the exhaled air is used as a specimen to non-invasively measure the amount of amino acid metabolism (Patent Document 3). According to general knowledge, the ketogenic diet ingested by an animal is metabolized in the animal body, and part of it becomes acetone, which is used as exhalation or gas discharged from the skin or mucous membrane, and is automatically excreted from the body to the body. As a method for measuring acetone in gas, a multi-function breath analyzer (Patent Document 4), a breath measurement device (Patent Document 5), and the like are known. In addition, a system for estimating the diabetes index value using the amount of expiratory acetone is known (Patent Document 6). [Prior Art Literature] [Patent Literature] Patent Literature 1: International Publication No. 2017/038101 Patent Literature 2: International Publication No. 2016/013617 Patent Literature 3: Japanese Patent No. 5938219 Patent Literature 4: Japanese Patent No. 5921562 Patent Document 5: Japanese Patent No. 5139186 Patent Document 6: Japanese Patent Laid-Open No. 2015-102381 [Non-Patent Document] Non-Patent Document 1: European Journal of Clinical Nu trition (2013) 67, 789-796

[發明所欲解決之問題] 在此之前,並未聽說有為了管理動物之生酮飲食之有效狀態而對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定之監測裝置。更未聽說有為了於攝取生酮飲食時管理生酮飲食之有效狀態,或者為了將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象來管理生酮飲食之有效狀態,或者作為食用攝取生酮飲食之輔助方法、或作為對是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質進行核查或判斷之方法,而對自動物體內排出體外之氣體中之丙酮量進行測定之監測裝置。 於動物之生酮飲食之有效狀態之管理中,認為只要可非侵入性地以即時或持續等方式對排出體外之氣體中之丙酮量進行測定,來監測動物之生酮飲食作為酮體來源之代謝狀態,便可對生酮飲食之有效狀態個別地進行管理。即,此種裝置之開發即為課題所在。 [解決問題之技術手段] 本發明人經過銳意努力,發現了對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法,從而完成了本發明。 根據本發明,其提供以下發明。 [1]一種監測裝置,其為了管理生酮飲食之有效狀態,而對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次測定。 [2]如[1]所記載之監測裝置,其為了管理生酮飲食之有效狀態,而進行1次及/或複數次測定,且上述動物係攝取生酮飲食能有效醫治之疾病之患者及/或準患者。 [3]如[1]所記載之監測裝置,其中上述生酮飲食之有效狀態之管理係為了與攝取生酮飲食前後之動物體內之代謝一併管理生酮飲食之攝取而進行1次及/或複數次測定。 [4]如[1]所記載之監測裝置,其中上述生酮飲食之有效狀態之管理係為了核查對象者對生酮飲食之有效狀態之維持、改善之適性而進行1次及/或複數次測定。 又,本案發明之生酮飲食監測裝置之特徵在於:其係對生酮飲食之有效性進行監測者,且具有:攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資訊;丙酮濃度測定部,其對自上述動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及判定部,其基於藉由上述攝取資訊獲取部所獲取之上述生酮飲食之攝取量之資訊、及藉由上述丙酮濃度測定部所測定之上述丙酮濃度之資訊,判定上述動物之上述生酮飲食之代謝狀態。 較佳為上述判定部係基於攝取上述生酮飲食前後之上述丙酮濃度之增減而進行上述判定。並且,較佳為於與攝取上述生酮飲食前相比,上述丙酮濃度表現出增加傾向之情形時,上述判定部判定上述動物係將上述生酮飲食作為酮體來源而代謝之狀態、或者上述動物係可將上述生酮飲食作為酮體來源而代謝之體況或體質。 [發明之效果] 根據本發明,其可提供一種對自動物體內排出體外之氣體中之代謝物量進行1次及/或複數次經時測定、監測之裝置及其使用方法。並且,藉由提供本發明之監測裝置及其使用方法,可於攝取生酮飲食時管理生酮飲食之有效狀態,或者可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象來管理生酮飲食之有效狀態,或者作為食用攝取生酮飲食之輔助方法而對是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質進行核查或判斷。 根據本發明,其可提供一種於動物攝取了生酮飲食之情形時,對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法。 根據本發明,其可提供一種對自攝取生酮飲食能有效醫治之疾病之患者及/或準患者的體內排出體外之氣體中之丙酮量進行1次及/或複數次經時測定、監測之裝置及其使用方法。 根據本發明之監測裝置,其可對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定,而管理動物之生酮飲食之有效狀態。 根據本發明之監測裝置,其可於動物攝取了生酮飲食之情形時,對自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之代謝物量進行測定,而管理動物之生酮飲食之有效狀態。 根據本發明之監測裝置,其可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象,對自動物體內排出體外之氣體中之丙酮量進行測定,並將該酮體來源之代謝率考慮在內,而進行飲食管理,如調整飲食中之糖類與脂類之平衡性等。關於生酮飲食,因口味欠佳,故存在難以出於喜愛而大量攝取之情形。 根據本發明,其可藉由一面進行監測一面調整攝取,而僅按充分必要量即適度量進行攝食,從而可避免過度攝取並不喜愛之生酮飲食。根據本發明,其兼具如下效果,即:可藉由一面進行監測一面調整生酮飲食之攝取(藉由使能有效維持或改善體況之生酮飲食之攝食量變得明確),而使攝食動物(尤其是人)有意識或無意識地進行攝食。 根據本發明之監測裝置,其可對自動物體內排出體外之氣體中之丙酮量進行測定,而核查或判斷是否為可將生酮飲食作為酮體來源有效地代謝之體況或體質。 與本發明相關之更多特徵可根據本說明書之記述、隨附圖式而明瞭。又,上述內容以外之課題、構成及效果可藉由以下實施形態之說明而明瞭。[Problems to be solved by the invention] Prior to this, I have not heard of any gas (exhalation, evapotranspiration from the skin or mucous membranes) that is expelled from the automatic body in order to manage the effective state of the ketogenic diet of animals Monitoring device for measuring the amount of metabolites. It has never been heard that there is an effective state for managing the ketogenic diet when ingesting the ketogenic diet, or for managing the effective state of the ketogenic diet for patients and / or prospective patients whose diseases can be effectively treated by ingesting the ketogenic diet, Or as an auxiliary method for eating and ingesting a ketogenic diet, or as a method for checking or judging whether the ketogenic diet can be effectively metabolized as a source of ketone bodies, and to expel the gas from the body of the automatic body A monitoring device for measuring the amount of acetone. In the management of the effective state of the animal's ketogenic diet, it is considered that as long as the amount of acetone in the gas discharged from the body can be measured in a non-invasive manner in an immediate or continuous manner, to monitor the animal's ketogenic diet as a source of ketone bodies The metabolic state allows individual management of the effective state of the ketogenic diet. That is, the development of such devices is the subject. [Technical Means for Solving the Problem] The inventor has made strenuous efforts to find a device for measuring and monitoring the amount of acetone in the gas discharged from the automatic body once and / or multiple times and its use method, and completed The present invention. According to the present invention, it provides the following invention. [1] A monitoring device that measures the amount of acetone in the gas discharged from an automatic object in order to manage the effective state of the ketogenic diet, and / or measures the amount of acetone once and / or multiple times. [2] The monitoring device as described in [1], which performs one and / or multiple measurements in order to manage the effective state of the ketogenic diet, and the above-mentioned animals are patients with diseases that can be effectively treated by ingesting the ketogenic diet and / Or prospective patients. [3] The monitoring device according to [1], wherein the management of the effective state of the ketogenic diet described above is performed once to manage the intake of the ketogenic diet together with the metabolism of the animal body before and after ingesting the ketogenic diet and // Or multiple determinations. [4] The monitoring device as described in [1], wherein the management of the effective state of the ketogenic diet is performed once and / or multiple times in order to verify the fitness of the subject to maintain and improve the effective state of the ketogenic diet Determination. In addition, the ketogenic diet monitoring device of the invention of the present invention is characterized in that it monitors the effectiveness of the ketogenic diet, and has: an intake information acquiring section that acquires information on the amount of ketogenic diet ingested into the animal An acetone concentration measuring section, which measures the amount of acetone in the gas discharged from the animal body, that is, the acetone concentration; and a judgment section, which is based on the intake amount of the ketogenic diet obtained by the intake information obtaining section Information and the information on the acetone concentration measured by the acetone concentration measuring section to determine the metabolic state of the ketogenic diet of the animal. Preferably, the determination unit performs the determination based on an increase or decrease in the acetone concentration before and after ingesting the ketogenic diet. Furthermore, it is preferable that the determination unit determines that the animal is metabolizing the ketogenic diet as a source of ketone bodies when the acetone concentration shows an increasing tendency compared to before the intake of the ketogenic diet, or The animal system can use the ketogenic diet as a source of ketone body to metabolize the body condition or constitution. [Effects of the Invention] According to the present invention, it is possible to provide a device for measuring and monitoring the amount of metabolites in the gas discharged from an automatic body once and / or multiple times, and a method of using the same. Moreover, by providing the monitoring device of the present invention and the method of use thereof, the effective state of the ketogenic diet can be managed when ingesting the ketogenic diet, or patients and / or quasi-patients who can effectively treat diseases by ingesting the ketogenic diet can be used The subject manages the effective state of the ketogenic diet, or as an auxiliary method of eating and ingesting the ketogenic diet, checks or judges whether the ketogenic diet can be effectively metabolized as a source of ketone body. According to the present invention, it can provide a device for measuring and monitoring the amount of acetone in the gas discharged from the automatic body once and / or multiple times over time when the animal ingests a ketogenic diet and its use method . According to the present invention, it can provide a method for measuring and monitoring the amount of acetone in the gas discharged from the body of patients and / or quasi-patients who can effectively treat diseases by ingesting the ketogenic diet. Device and method of use. According to the monitoring device of the present invention, it can measure the amount of metabolites in the gas (exhalation, evapotranspiration from the skin or mucous membrane) discharged from the automatic object, and manage the effective state of the animal's ketogenic diet. According to the monitoring device of the present invention, when an animal ingests a ketogenic diet, it can measure the amount of metabolites in the gas (exhalation, evapotranspiration from the skin or mucous membranes) discharged from the automatic body to manage the animal The effective state of the ketogenic diet. According to the monitoring device of the present invention, it can target patients and / or quasi-patients with diseases that can be effectively treated by ingesting a ketogenic diet, and can measure the amount of acetone in the gas discharged from the automatic body and source the ketone body Take into account the metabolic rate, and carry out diet management, such as adjusting the balance of sugars and lipids in the diet. Regarding the ketogenic diet, because of its poor taste, it is difficult to consume a large amount of it out of affection. According to the present invention, it is possible to adjust the intake by monitoring while monitoring the food intake by only the necessary and sufficient amount, thereby avoiding excessive intake of a ketogenic diet that is not favorite. According to the present invention, it has the effect that the intake of the ketogenic diet can be adjusted by monitoring while monitoring (by making the intake of the ketogenic diet effective to maintain or improve the body condition clear), and feeding animals ( Especially people) eat consciously or unconsciously. According to the monitoring device of the present invention, it can measure the amount of acetone in the gas discharged from the automatic body, and check or judge whether it is a body condition or constitution that can effectively metabolize the ketogenic diet as a source of ketone bodies. Further features related to the present invention will be apparent from the description in this specification and the accompanying drawings. In addition, problems, configurations, and effects other than the above can be made clear by the description of the following embodiments.

以下,對本發明之較佳之實施形態詳細地進行說明,但本發明並不限定於以下所述之各個形態。 作為於本發明中可使用之對象之動物,可列舉任意之哺乳動物,例如可列舉:小鼠、大鼠、倉鼠、豚鼠等嚙齒類,兔子等兔科,豬、牛、山羊、馬、綿羊等蹄科,狗、貓等貓科,人、猿猴、羅猴、食蟹猴、狨猴、猩猩、黑猩猩等靈長類等。哺乳動物較佳為嚙齒類(小鼠等)或靈長類(人等),更佳為靈長類,進而更佳為人。 於本發明中,所謂生酮飲食之有效狀態,係指動物自體外攝取生酮飲食,並將生酮飲食有效地用於動物之活體維持或動物之生活活動之狀態。生酮飲食之有效狀態可由將生酮飲食作為酮體來源而有效地代謝之狀態進行判斷,例如可根據自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量之狀態進行判斷。自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量可按絕對量及/或相對量進行管理。又,由於存在動物個體差異,故而對於自動物體內排出體外之氣體(呼氣、來自皮膚或黏膜之蒸散物)中之丙酮量,只要是根據同一個體中未攝取生酮飲食之時期與攝取生酮飲食之時期、或者生酮飲食之攝取前或攝取後之丙酮量之上升、降低及/或增加等來進行判斷即可,若與攝取生酮飲食前相比,表現出一定之增加傾向,則可判斷出其具有上述效果。例如,該增加傾向更佳為於統計學上表現出有意義之差。 又,即便為同一個體中未攝取生酮飲食之時期與攝取生酮飲食之時期、或者生酮飲食之攝取前或攝取後之丙酮量之差固定的狀態,其效果亦得到維持,從而可判斷出其較佳。 於本發明中,所謂生酮飲食之有效狀態之管理,係指掌握生酮飲食作為酮體來源被有效地代謝之狀態,並試圖於目標範圍內維持及/或改善動物之體況。 於本發明中,所謂生酮飲食,係指可於動物活體內產生酮體之飲食或食品。例如為高脂肪飲食、中鏈脂肪酸飲食、酮體酯、調配有酮原性胺基酸之食品。又,於本發明中,有時將該等生酮飲食稱為酮體來源飲食。 其中,作為用以治療癌症之生酮飲食或其組合,例如可列舉生酮飲食、尤其是高脂肪飲食(例如所謂之「糖類限制高脂肪飲食」)。上述自癌症患者之體內排出體外之氣體例如可列舉呼氣、自皮膚或黏膜排出體外之氣體。 於本發明中,生酮飲食之有效狀態受到管理之動物可為攝取生酮飲食能有效醫治之疾病之患者及/或準患者等,於本發明中,攝取生酮飲食能有效醫治之疾病可列舉肥胖症、循環器官疾病、2型糖尿病、癲癇、痤瘡、癌症、多嚢性卵巢症候群、神經障礙、阿茲海默症、帕金森氏症、頭部外傷。 於本發明中,所謂攝取生酮飲食能有效醫治之疾病之患者,係指被診斷出患有上述疾病者,所謂準患者,係指被診斷出有可能罹患上述疾病、或存在罹患上述疾病之傾向及/或徵兆者。又,所謂準患者,進而包括自遺傳學上而言罹患上述疾病之可能性較高者、及/或基於自身意願希望攝取生酮飲食以預防上述疾病者。 於本發明中,可藉由本發明裝置進行監測,以便於攝取生酮飲食之前後確定生酮飲食之攝取量。又,可藉由本發明裝置進行監測,以便核查或判斷上述生酮飲食之有效狀態受到管理之動物是否為可於攝取生酮飲食後將生酮飲食作為酮體來源而有效地代謝之體況或體質。 圖1及圖2係表示本實施形態之監測裝置之例之功能方塊圖。 例如如圖1所示,監測裝置1具備監測終端裝置2與監測管理裝置3。監測終端裝置2與監測管理裝置3經由通信電路4而連接,可相互進行資訊之收發。監測終端裝置2具有包含丙酮濃度測定部21a之測定部21與包含判定顯示部22a之顯示部22。並且,監測管理裝置3具有資料獲取部31與判定部32。 監測終端裝置2之丙酮濃度測定部21a對自動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定。並且,判定顯示部22a顯示藉由監測管理裝置3之判定部32所獲得之判定結果。 監測管理裝置3之資料獲取部31獲取生酮飲食之攝取資訊、丙酮濃度之資訊、及攝取生酮飲食之動物之個體資訊。生酮飲食之攝取資訊中包含向動物體內攝取之生酮飲食之攝取量之資訊,進而亦可包含生酮飲食之攝取時刻、攝取期間、種類等資訊中之至少一者。並且,動物之個體資訊中可包含動物之種類、年齡、性別、體格、體況、體質、患病名稱等資訊中之至少一者。 生酮飲食之攝取資訊與動物之個體資訊係自設置於監測終端裝置2或監測管理裝置3之未圖示之輸入機構輸入至資料獲取部31。即,資料獲取部31作為攝取資訊獲取部,獲取生酮飲食之攝取資訊。並且,丙酮濃度之資訊係自丙酮濃度測定部21a獲取。 判定部32基於生酮飲食之攝取資訊與丙酮濃度之資訊,而判定動物之生酮飲食之代謝狀態。判定部32對生酮飲食是否被作為酮體來源而有效地代謝,即動物體內是否產生有酮體進行判定。判定部32例如基於攝取生酮飲食前後之丙酮濃度之增減而進行代謝狀態之判定。於與生酮飲食之攝取前相比,攝取後之丙酮濃度表現出增加傾向之情形時,判定部32判定該動物係將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。 判定部32例如基於動物之單位體重(Kg)之生酮飲食攝取量(g)、及攝取生酮飲食前後之丙酮濃度之差,算出因攝取生酮飲食而產生之丙酮濃度之增加率。並且,與預先設定之基準值進行比較,於超過基準值之情形時,丙酮濃度表現出增加傾向,因此判斷為動物係將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。另一方面,於基準值以下之情形時丙酮濃度未表現出增加傾向,因此判斷為動物係未將生酮飲食作為酮體來源而有效地代謝之狀態、或者動物並非係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。又,例如,亦可對丙酮濃度之增加率是否屬於被設定了階梯性範圍之複數個代謝等級(等級1~5)中之某一者進行判定。 亦可基於動物之個體資訊,來修正基準值或代謝等級之範圍。例如,亦可為於成人男性等體格較大之動物之情形時向提高基準值之方向修正,而於成人女性或兒童等體格較小之動物之情形時,向降低基準值之方向修正。 判定部32之判定結果顯示於監測終端裝置2之判定顯示部22a。因此,藉由察看判定顯示部22a,可瞭解攝取生酮飲食對該動物是否有效。修正可依據行政機關等所發表之統計資訊、論文發表/學會發表等公開資訊、基於個人積累之資料而獲得之非公開資訊等來進行。該修正可人為地進行,亦可利用AI(人工智能)等功能來實現。 根據具有上述構成之監測裝置1,可基於判定結果而確定生酮飲食自下次起之攝取量。又,可判斷出動物是否係可將生酮飲食作為酮體來源而有效地代謝之體況或體質。並且,亦可藉由持續地進行記錄,而掌握動物之體況或體質之變化。 根據監測裝置1,關於生酮飲食,即,可將攝取生酮飲食能有效醫治之疾病之患者及/或準患者作為對象而進行飲食管理,如調整飲食中之糖類與脂類之平衡性等者,因口味欠佳,故存在難以出於喜愛而大量攝取之情形,但可一面藉由監測裝置1進行監測一面調整攝取,因此可僅按充分必要量即適度量進行攝取,從而可避免過度攝取並不喜愛之生酮飲食。根據監測裝置1,能有效維持或改善體況之生酮飲食之攝食量變得明確。因此,兼具可使攝食動物(尤其是人)有意識或無意識地進行攝食之效果。 監測裝置1可為將顯示測定結果之判定的判定部32與顯示判定之判定顯示部22a直接連接而於一處進行監測之裝置,亦可為通過通信電路4將包含上述測定部21及判定顯示部22a之監測終端裝置2與具有處理資料之資料獲取部31及判定生酮飲食之有效狀態之判定部32之監測管理裝置3連接的監測裝置1(圖1)。通信電路4可列舉電波、各種公知之無線通信線路或有線通信線路等。監測可為實時,亦可有一定之時間差。又,監測可於一處進行,亦可於複數處,例如患者本人、醫生、護士、檢查技師、營養師、管理設備、生酮飲食生產者等處進行。 又,亦可包含監測終端裝置、及監測管理裝置,其中監測終端裝置包含測定部、判定顯示部、及接收並顯示判斷之判斷顯示部;監測管理裝置包含資料獲取部、判定部、儲存判定部之判定之判定儲存部、及根據所儲存之判定進行判斷之判定判斷部(圖2)。 監測終端裝置可為如同手錶或眼鏡般之形狀,亦可為裝飾品或皮帶等容易穿戴於身上之任何形態。進而,亦可具有連動地管理複數個監測終端裝置之監測管理伺服器。藉由監測管理伺服器,例如亦可用以根據複數個患者之治療成績而確定通常最佳之治療量。 作為監測終端裝置或監測管理裝置,可使用包括個人電腦、超級電腦等在內之所有數位電腦,亦可使用行動電話、智慧型手機、平板、警報裝置等。 圖3係表示本實施形態之監測裝置之整體構成之功能方塊圖。 監測終端裝置2包含測定丙酮濃度之丙酮濃度測定部、及顯示來自判定等發送部之資料之顯示部,顯示部中包含判定顯示部。又,亦可具有顯示來自判定等發送部之資料之判斷顯示部。進而,亦可包含1個或複數個對生酮飲食之有效狀態管理有用之其他測定部。 監測管理裝置3包含獲取測定資料之資料獲取部、記錄測定資料之記錄部、及根據資料判定被代謝之酮體來源飲食量之判定部。又,亦可具有預先儲存判定之判定儲存部、及根據所儲存之判定核查或判斷是否需要調整飲食之攝食量或脂肪量、及可否適應生酮飲食之判定判斷部。來自判定部之判定及來自判定判斷部之判斷經由判定等發送部被發送至判定顯示部或判斷顯示部並顯示於監測終端裝置。監測管理裝置中亦可包含資料記錄部。 圖4係表示本實施形態之監測裝置之構成之功能方塊圖。 監測裝置1具有監測終端裝置2A~2C、監測管理裝置3A~3C、及將其等連接之通信電路4A~4C。可具有複數個監測終端裝置,亦可具有1個及/或複數個管理複數個監測終端裝置之監測管理裝置,進而,亦可具有用以於上位管理監測管理裝置之監測管理伺服器。 本發明包含使用本發明之監測裝置之方法或使用方法、生酮飲食之評估方法、生酮飲食攝取量之管理方法、攝食生酮飲食能有效醫治之動物之核查等使用本發明之監測裝置之一切形態,且可應用於所有形態。 以上,對本發明之實施形態進行了詳細說明,但本發明並不限定於上述實施形態,而可於不脫離申請專利範圍所記載之本發明精神之範圍內,進行各種設計變更。Hereinafter, preferred embodiments of the present invention will be described in detail, but the present invention is not limited to the following embodiments. Examples of animals that can be used in the present invention include any mammals, and examples include rodents such as mice, rats, hamsters, and guinea pigs, rabbits such as rabbits, pigs, cows, goats, horses, and sheep. Primates such as ungulates, dogs, cats and other cats, humans, apes, rhesus monkeys, cynomolgus monkeys, marmosets, orangutans, chimpanzees, etc. The mammal is preferably a rodent (mouse, etc.) or a primate (human, etc.), more preferably a primate, and even more preferably a human. In the present invention, the effective state of the ketogenic diet refers to a state in which the animal ingests the ketogenic diet from outside the body, and effectively uses the ketogenic diet for the living maintenance of the animal or the life activity of the animal. The effective state of the ketogenic diet can be judged by the state of effectively metabolizing the ketogenic diet as a source of ketone bodies, for example, the amount of acetone in the gas (exhalation, evapotranspiration from the skin or mucous membranes) that is excreted from the automatic body To determine the state of the situation. The amount of acetone in the gas (exhalation, evapotranspiration from the skin or mucous membranes) discharged from the body of the automatic body can be managed in absolute and / or relative amounts. In addition, due to individual animal differences, the amount of acetone in the gas (exhalation, evapotranspiration from the skin or mucous membranes) in the automatic body is based on the time and intake of the ketogenic diet in the same individual. The period of ketone diet, or the increase, decrease, and / or increase in the amount of acetone before or after intake of the ketogenic diet can be judged. If it shows a certain increase tendency compared with before intake of the ketogenic diet, It can be judged that it has the above effect. For example, the tendency to increase is more preferably a statistically significant difference. In addition, even if the difference between the time when the ketogenic diet is not taken and the time when the ketogenic diet is taken, or the amount of acetone before or after the ketogenic diet is fixed in the same individual, the effect is maintained and it can be judged Outstanding. In the present invention, the management of the effective state of the ketogenic diet refers to grasping the state in which the ketogenic diet is effectively metabolized as a source of ketone bodies, and trying to maintain and / or improve the physical condition of the animal within the target range. In the present invention, the ketogenic diet refers to a diet or food that can produce ketone bodies in the living body of an animal. Examples include high-fat diets, medium-chain fatty acid diets, ketone body esters, and foods formulated with ketogenic amino acids. In the present invention, such ketogenic diets are sometimes referred to as ketone-derived diets. Among them, as a ketogenic diet for treating cancer or a combination thereof, for example, a ketogenic diet, especially a high-fat diet (for example, a so-called "sugar-limited high-fat diet") may be mentioned. Examples of the gas discharged from the body of a cancer patient include exhalation and gas discharged from the skin or mucous membrane. In the present invention, the animal whose effective state of the ketogenic diet is managed can be a patient and / or prospective patient who can effectively treat diseases ingested by the ketogenic diet. In the present invention, the diseases effectively treated by ingesting the ketogenic diet can be Examples include obesity, circulatory organ diseases, type 2 diabetes, epilepsy, acne, cancer, polycystic ovarian syndrome, neurological disorders, Alzheimer's disease, Parkinson's disease, and head trauma. In the present invention, a patient who is effectively treated by taking a ketogenic diet refers to a patient diagnosed with the above-mentioned diseases, and a quasi-patient refers to a patient who is diagnosed as having the above-mentioned diseases or is suffering from the above-mentioned diseases. Prone and / or symptoms. In addition, the so-called quasi-patients include those who are genetically more likely to suffer from the above-mentioned diseases, and / or those who wish to ingest a ketogenic diet based on their own wishes to prevent the above-mentioned diseases. In the present invention, the device of the present invention can be used for monitoring to determine the intake of the ketogenic diet before and after ingesting the ketogenic diet. In addition, the device of the present invention can be used for monitoring to check or judge whether the animal whose effective state of the ketogenic diet is managed is a body condition that can be effectively metabolized by taking the ketogenic diet as a source of ketone bodies after ingesting the ketogenic diet constitution. 1 and 2 are functional block diagrams showing an example of the monitoring device of this embodiment. For example, as shown in FIG. 1, the monitoring device 1 includes a monitoring terminal device 2 and a monitoring management device 3. The monitoring terminal device 2 and the monitoring management device 3 are connected via a communication circuit 4 and can exchange information with each other. The monitoring terminal device 2 includes a measurement unit 21 including an acetone concentration measurement unit 21a and a display unit 22 including a determination display unit 22a. In addition, the monitoring management device 3 includes a data acquisition unit 31 and a determination unit 32. The acetone concentration measuring part 21a of the monitoring terminal device 2 measures the acetone concentration, which is the amount of acetone in the gas discharged from the body of the automatic object. In addition, the determination display unit 22a displays the determination result obtained by the determination unit 32 of the monitoring management device 3. The data acquisition part 31 of the monitoring management device 3 acquires the intake information of the ketogenic diet, the information of the acetone concentration, and the individual information of the animals ingesting the ketogenic diet. The intake information of the ketogenic diet includes information on the amount of intake of the ketogenic diet ingested into the animal body, and may further include at least one of information such as intake time, intake period, and type of the ketogenic diet. In addition, the individual information of the animal may include at least one of the information such as the type, age, sex, physique, physical condition, physique, and disease name of the animal. The intake information of the ketogenic diet and the individual information of the animals are input to the data acquisition unit 31 from an input mechanism (not shown) provided in the monitoring terminal device 2 or the monitoring management device 3. That is, the data acquisition unit 31 serves as an intake information acquisition unit to acquire intake information of the ketogenic diet. In addition, the acetone concentration information is obtained from the acetone concentration measuring unit 21a. The determination unit 32 determines the metabolic state of the ketogenic diet of the animal based on the intake information of the ketogenic diet and the information of the acetone concentration. The determination unit 32 determines whether the ketogenic diet is effectively metabolized as a source of ketone bodies, that is, whether ketone bodies are produced in the animal. The determination unit 32 determines the metabolic state based on, for example, the increase or decrease in the acetone concentration before and after ingesting the ketogenic diet. When the acetone concentration after ingestion shows a tendency to increase compared with before the intake of the ketogenic diet, the determination section 32 determines that the animal system is effectively metabolizing the ketogenic diet as a source of ketone bodies, or the animal system may A ketogenic diet as a source of ketone bodies that effectively metabolizes body condition or physique. The determination unit 32 calculates the increase rate of the acetone concentration due to the intake of the ketogenic diet based on, for example, the amount of ketogenic diet intake (g) per unit body weight (Kg) of the animal and the difference between the acetone concentration before and after the ketogenic diet. Furthermore, when compared with a preset reference value, the acetone concentration tends to increase when the reference value is exceeded, so it is determined that the animal system is effectively metabolizing the ketogenic diet as a ketone body source, or the animal system can A ketogenic diet as a source of ketone bodies that effectively metabolizes body condition or physique. On the other hand, when the acetone concentration does not show a tendency to increase when the reference value is less than the reference value, it is judged that the animal system does not use the ketogenic diet as a source of ketone bodies and is effectively metabolized, or the animal does not adopt the ketogenic diet A body condition or constitution that is derived from ketone bodies and efficiently metabolized. In addition, for example, it may be determined whether the increase rate of the acetone concentration belongs to one of a plurality of metabolic levels (levels 1 to 5) set in a stepped range. The reference value or the range of metabolic grade can also be corrected based on the individual information of the animal. For example, it may be corrected in the direction of increasing the reference value in the case of larger animals such as adult males, and in the direction of decreasing the reference value in the case of smaller animals such as adult females or children. The determination result of the determination unit 32 is displayed on the determination display unit 22 a of the monitoring terminal device 2. Therefore, by looking at the judgment display section 22a, it can be understood whether ingesting the ketogenic diet is effective for the animal. Revisions can be made based on statistical information published by administrative agencies, public information such as paper publications / society publications, and non-public information obtained based on personally accumulated data. This correction can be carried out artificially, or it can be realized by using functions such as AI (artificial intelligence). According to the monitoring device 1 having the above configuration, the intake amount of the ketogenic diet from the next time can be determined based on the determination result. In addition, it can be judged whether the animal is a body condition or constitution that can effectively metabolize the ketogenic diet as a source of ketone bodies. In addition, by continuously recording, you can grasp the changes in the animal's physical condition or physique. According to the monitoring device 1, regarding the ketogenic diet, that is, patients and / or quasi-patients who can effectively treat diseases ingested by the ketogenic diet can be targeted for diet management, such as adjusting the balance of sugars and lipids in the diet, etc. In addition, due to poor taste, it is difficult to ingest in large quantities out of affection, but the ingestion can be adjusted while monitoring by the monitoring device 1, so ingestion can be carried out only in a sufficient amount, that is, in an appropriate amount, to avoid excessive Take a ketogenic diet that you do n’t like. According to the monitoring device 1, the intake of the ketogenic diet which can effectively maintain or improve the body condition becomes clear. Therefore, it has the effect of allowing the feeding animals (especially humans) to eat consciously or unconsciously. The monitoring device 1 may be a device that directly connects the determination unit 32 that displays the determination of the measurement result and the determination display unit 22a that displays the determination to monitor at one place, or may include the measurement unit 21 and the determination display via the communication circuit 4 The monitoring terminal device 2 of the unit 22a is connected to the monitoring management device 3 having the data acquisition unit 31 for processing data and the monitoring management device 3 of the determination unit 32 for determining the effective state of the ketogenic diet (FIG. 1). The communication circuit 4 may include radio waves, various well-known wireless communication lines, or wired communication lines. The monitoring can be real-time or have a certain time difference. In addition, the monitoring can be carried out in one place, or in a plurality of places, such as the patient himself, a doctor, a nurse, an inspection technician, a nutritionist, a management device, a ketogenic diet producer, and so on. Furthermore, it may also include a monitoring terminal device and a monitoring management device, wherein the monitoring terminal device includes a measuring unit, a judgment display unit, and a judgment display unit that receives and displays judgments; the monitoring management device includes a data acquisition unit, a judgment unit, and a storage judgment unit The judgment storage unit for the judgment and the judgment judgment unit for judging based on the stored judgment (FIG. 2). The monitoring terminal device may be in a shape like a watch or glasses, or any form that is easy to wear on the body such as an ornament or a belt. Furthermore, there may be a monitoring management server that manages a plurality of monitoring terminal devices in a linked manner. By monitoring the management server, for example, it can also be used to determine the usually optimal amount of treatment based on the treatment results of multiple patients. As the monitoring terminal device or monitoring management device, all digital computers including personal computers, super computers, etc. can be used, as well as mobile phones, smart phones, tablets, alarm devices, etc. FIG. 3 is a functional block diagram showing the overall configuration of the monitoring device of this embodiment. The monitoring terminal device 2 includes an acetone concentration measuring unit that measures the concentration of acetone, and a display unit that displays data from a transmitting unit such as a judgment. The display unit includes a judgment display unit. Furthermore, it may have a judgment display unit that displays data from a transmission unit such as judgment. Furthermore, one or a plurality of other measurement units useful for managing the effective state of the ketogenic diet may be included. The monitoring management device 3 includes a data acquisition unit that acquires measurement data, a recording unit that records measurement data, and a determination unit that determines the amount of ketone body-derived diet that is metabolized based on the data. In addition, a judgment storage section that stores judgments in advance, and a judgment judgment section that checks or judges whether it is necessary to adjust the food intake or fat amount of the diet based on the stored judgments and whether it can adapt to the ketogenic diet. The judgment from the judgment section and the judgment from the judgment judgment section are transmitted to the judgment display section or judgment display section via the judgment transmission section and displayed on the monitoring terminal device. The data management unit may also be included in the monitoring management device. FIG. 4 is a functional block diagram showing the configuration of the monitoring device of this embodiment. The monitoring device 1 includes monitoring terminal devices 2A to 2C, monitoring management devices 3A to 3C, and communication circuits 4A to 4C that connect them. There may be a plurality of monitoring terminal devices, one and / or a plurality of monitoring management devices that manage the plurality of monitoring terminal devices, and furthermore, a monitoring management server for supervising the monitoring management device. The present invention includes the method or method of using the monitoring device of the present invention, the method of evaluating the ketogenic diet, the management method of the intake of the ketogenic diet, the verification of animals that can be effectively treated by the ketogenic diet, etc. All forms, and can be applied to all forms. The embodiments of the present invention have been described in detail above, but the present invention is not limited to the above-mentioned embodiments, and various design changes can be made without departing from the spirit of the invention described in the scope of the patent application.

1‧‧‧監測裝置1‧‧‧Monitoring device

2‧‧‧監測終端裝置2‧‧‧Monitoring terminal device

2A‧‧‧監測終端裝置A2A‧‧‧Monitoring terminal device A

2B‧‧‧監測終端裝置B2B‧‧‧Monitoring terminal device B

2C‧‧‧監測終端裝置C2C‧‧‧Monitoring terminal device C

3‧‧‧監測管理裝置3‧‧‧Monitoring management device

3A‧‧‧監測管理裝置A3A‧‧‧Monitoring management device A

3B‧‧‧監測管理裝置B3B‧‧‧Monitoring management device B

3C‧‧‧監測管理裝置C3C‧‧‧Monitoring management device C

4‧‧‧通信電路4‧‧‧Communication circuit

4A‧‧‧通信電路A4A‧‧‧Communication circuit A

4B‧‧‧通信電路B4B‧‧‧Communication circuit B

4C‧‧‧通信電路C4C‧‧‧Communication circuit C

5‧‧‧監測管理伺服器5‧‧‧Monitoring management server

21‧‧‧測定部21‧‧‧Measurement Department

21a‧‧‧丙酮濃度測定部21a‧‧‧Acetone concentration measurement department

22‧‧‧顯示部22‧‧‧Display

22a‧‧‧判定顯示部22a‧‧‧judgment display unit

31‧‧‧資料獲取部31‧‧‧ Data Acquisition Department

32‧‧‧判定部32‧‧‧Judgment Department

圖1係表示本實施形態之監測裝置之例之功能方塊圖。 圖2係表示本實施形態之監測裝置之例之功能方塊圖。 圖3係表示本實施形態之監測裝置之整體構成之功能方塊圖。 圖4係表示本實施形態之監測裝置之構成之功能方塊圖。FIG. 1 is a functional block diagram showing an example of the monitoring device of this embodiment. FIG. 2 is a functional block diagram showing an example of the monitoring device of this embodiment. FIG. 3 is a functional block diagram showing the overall configuration of the monitoring device of this embodiment. FIG. 4 is a functional block diagram showing the configuration of the monitoring device of this embodiment.

Claims (7)

一種監測裝置,其為了管理生酮飲食之有效狀態,而對自動物體內排出體外之氣體中之丙酮量進行1次及/或複數次測定。A monitoring device which measures the amount of acetone in the gas discharged from the automatic body in order to manage the effective state of the ketogenic diet. 如請求項1之監測裝置,其為了管理生酮飲食之有效狀態,而進行1次及/或複數次測定,且上述動物係攝取生酮飲食能有效醫治之疾病之患者及/或準患者。For the monitoring device according to claim 1, in order to manage the effective state of the ketogenic diet, it is measured once and / or multiple times, and the above-mentioned animals are patients and / or quasi-patients who can effectively treat diseases by ingesting the ketogenic diet. 如請求項1之監測裝置,其中上述生酮飲食之有效狀態之管理係為了與攝取生酮飲食前後之動物體內之代謝一併管理生酮飲食之攝取而進行1次及/或複數次測定。The monitoring device according to claim 1, wherein the management of the effective state of the ketogenic diet is performed once and / or multiple times in order to manage the intake of the ketogenic diet together with the metabolism of the animal body before and after ingesting the ketogenic diet. 如請求項1之監測裝置,其中上述生酮飲食之有效狀態之管理係為了核查對象者對生酮飲食之有效狀態之維持、改善之適性而進行1次及/或複數次測定。The monitoring device according to claim 1, wherein the above-mentioned management of the effective state of the ketogenic diet is performed once and / or multiple times in order to check the maintenance and improvement of the effective state of the ketogenic diet by the subject. 一種生酮飲食監測裝置,其特徵在於: 其係對生酮飲食之有效性進行監測者,且具有: 攝取資訊獲取部,其獲取攝取至動物體內之生酮飲食之攝取量之資訊; 丙酮濃度測定部,其對自上述動物體內排出體外之氣體中之丙酮量即丙酮濃度進行測定;及 判定部,其基於藉由上述攝取資訊獲取部所獲取之上述生酮飲食之攝取量之資訊、及藉由上述丙酮濃度測定部所測定之上述丙酮濃度之資訊,判定上述動物之上述生酮飲食之代謝狀態。A ketogenic diet monitoring device, characterized in that: it is a person who monitors the effectiveness of a ketogenic diet, and has: an intake information acquisition section that acquires information on the amount of ketogenic diet ingested into the animal; acetone concentration A measuring section that measures the amount of acetone in the gas discharged from the animal body, that is, the concentration of acetone; and a judging section that is based on information on the intake amount of the ketogenic diet obtained by the intake information obtaining section, and Based on the information of the acetone concentration measured by the acetone concentration measuring section, the metabolic state of the ketogenic diet of the animal is determined. 如請求項5之生酮飲食監測裝置,其中上述判定部係基於攝取上述生酮飲食前後之上述丙酮濃度之增減而進行上述判定。The ketogenic diet monitoring device according to claim 5, wherein the determination unit makes the determination based on an increase or decrease in the acetone concentration before and after ingesting the ketogenic diet. 如請求項6之生酮飲食監測裝置,其中於與攝取上述生酮飲食前相比,上述丙酮濃度表現出增加傾向之情形時,上述判定部判定上述動物係將上述生酮飲食作為酮體來源而代謝之狀態、或者上述動物係可將上述生酮飲食作為酮體來源而代謝之體況或體質。The ketogenic diet monitoring device according to claim 6, wherein the determination unit determines that the animal uses the ketogenic diet as a source of ketone body when the acetone concentration shows a tendency to increase compared to before the intake of the ketogenic diet The metabolic state, or the body condition or physique that the above ketogenic diet can be metabolized by the above ketogenic diet as a source of ketone bodies.
TW107111853A 2017-04-06 2018-04-03 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake TWI816666B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017076201 2017-04-06
JP2017-076201 2017-04-06
JP2017-162775 2017-08-25
JP2017162775A JP6968624B2 (en) 2017-04-06 2017-08-25 How to manage ketogenic diet intake

Publications (2)

Publication Number Publication Date
TW201842316A true TW201842316A (en) 2018-12-01
TWI816666B TWI816666B (en) 2023-10-01

Family

ID=64275121

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107111853A TWI816666B (en) 2017-04-06 2018-04-03 Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake

Country Status (3)

Country Link
JP (1) JP6968624B2 (en)
CN (1) CN110506211A (en)
TW (1) TWI816666B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114008452A (en) * 2019-06-18 2022-02-01 味之素株式会社 Method for evaluating food related to cognitive function

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7361517B2 (en) * 2018-07-17 2023-10-16 大阪瓦斯株式会社 Index value determination system, mitochondrial activity evaluation system, index value determination method, and mitochondrial activity evaluation method
CN112752827A (en) 2018-09-26 2021-05-04 松下知识产权经营株式会社 Warm color composite phosphor, wavelength converter, and light-emitting device
WO2021140640A1 (en) * 2020-01-10 2021-07-15 大阪瓦斯株式会社 Index value determination system, mitochondrial activiy evaluation system, index value determination method, and mitochondrial activity evaluation method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3822076B2 (en) * 2001-09-11 2006-09-13 株式会社タニタ Blood ketone body concentration measuring device
JP5696222B2 (en) * 2011-09-14 2015-04-08 株式会社Nttドコモ Diet support system and diet support method
MX371259B (en) * 2013-03-19 2020-01-23 Univ South Florida Compositions and methods for producing elevated and sustained ketosis.
CN103268414A (en) * 2013-05-20 2013-08-28 吉林市同益科技开发有限公司 Phenylketonuria managing method and system
JP2015141458A (en) * 2014-01-27 2015-08-03 株式会社タニタ diet support device, method, and program
US20160078782A1 (en) * 2014-09-17 2016-03-17 The Trustees Of Boston College Glucose Ketone Index for MetabolicTherapy
US20180000377A1 (en) * 2015-01-07 2018-01-04 Ntt Docomo, Inc. Information processing device, calorie management system, caloric balance estimation method, and program
CN105241828A (en) * 2015-08-19 2016-01-13 苏州华和呼吸气体分析研究所有限公司 CRDS acetone breath analyzer for noninvasively measuring blood ketone body level
US10675262B2 (en) * 2015-09-04 2020-06-09 Osaka University Development of dietary therapy in cancer
US10736548B2 (en) * 2016-05-18 2020-08-11 Invoy Holdings, Inc. Ketone measurement system for monitoring medical conditions
CN106338597A (en) * 2016-10-18 2017-01-18 哈尔滨工业大学深圳研究生院 Respiratory gas measuring method and system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114008452A (en) * 2019-06-18 2022-02-01 味之素株式会社 Method for evaluating food related to cognitive function

Also Published As

Publication number Publication date
TWI816666B (en) 2023-10-01
CN110506211A (en) 2019-11-26
JP6968624B2 (en) 2021-11-17
JP2018179960A (en) 2018-11-15

Similar Documents

Publication Publication Date Title
TWI816666B (en) Monitoring device for the effectiveness of the ketogenic diet and management method for the ketogenic diet intake
Lévy et al. Obstructive sleep apnoea syndrome
Uthaya et al. Altered adiposity after extremely preterm birth
van Loon et al. Application of a composite pain scale to objectively monitor horses with somatic and visceral pain under hospital conditions
Nechanitzky et al. Analysis of behavioral changes in dairy cows associated with claw horn lesions
Dunican et al. Prevalence of sleep disorders and sleep problems in an elite super rugby union team
Van Den Engel‐Hoek et al. Ultrasound of oral and masticatory muscles: why every neuromuscular swallow team should have an ultrasound machine
Braun et al. Evaluation of eating and rumination behaviour using a noseband pressure sensor in cows during the peripartum period
Tamura et al. Monitoring and evaluation of blood pressure changes with a home healthcare system
Byrne et al. Changes in resting and walking energy expenditure and walking speed during pregnancy in obese women
Kanoore Edul et al. The effects of arterial hypertension and age on the sublingual microcirculation of healthy volunteers and outpatients with cardiovascular risk factors
Lukas et al. A study of methods for evaluating the success of the transition period in early-lactation dairy cows
Tsuji et al. Respiratory mechanics and cerebral blood flow during heat‐induced hyperventilation and its voluntary suppression in passively heated humans
Idris et al. Relationship between chewing features and body mass index in young adolescents
Yu et al. Continuous positive airway pressure improves nocturnal polyuria in ischemic stroke patients with obstructive sleep apnea
Grodkowski et al. Comparison of different applications of automatic herd control systems on dairy farms–a review
Bromiker et al. Immature sucking patterns in infants of mothers with diabetes
Çekici et al. Determining energy requirement and evaluating energy expenditure in neurological diseases
Baross et al. Effects of isometric resistance training and detraining on ambulatory blood pressure and morning blood pressure surge in young normotensives
WO2018186481A1 (en) Device for monitoring ketogenic diet efficacy
Ren et al. Sleep fragmentation during rapid eye movement sleep and hypertension in obstructive sleep apnea
de Jesus et al. Skin conductance and behavioral pain scales in newborn infants.
Faraji et al. Thermoregulatory dynamics reveal sex-specific inflammatory responses to experimental autoimmune encephalomyelitis in mice: Implications for multiple sclerosis-induced fatigue in females
Arslan et al. Evaluation of the thickness and internal structure of the masseter muscle with ultrasonography in female bruxism patients
May Physiology of prenatal exercise and fetal development